Effectiveness of adjuvant radiotherapy after local excision of rectal cancer with deep submucosal invasion: a single-hospital, case–control analysis
- 355 Downloads
The role of postoperative radiation therapy (RT) after local excision (LE) of deep submucosal invasive rectal cancer remains unclear. We evaluated the efficacy of adjuvant RT after LE of early rectal cancer with deep submucosal invasion.
We screened 227 patients who underwent transanal excision or endoscopic removal of deep submucosal invasive rectal cancer between 1992 and 2012, of which 66 did not undergo radical surgery owing to the patient’s preference or poor medical conditions. Of these, 35 (53 %) underwent LE alone (LE group) and 31 (47 %) received adjuvant RT after LE (LE + RT group). Nine patients in the RT group received concurrent adjuvant chemotherapy with 5-fluorouracil. Two independent pathologists reviewed histological data.
The mean age of patients in the LE + RT and LE groups was 59.5 ± 9.6 and 55.3 ± 11.2 years, respectively. The mean follow-up duration was 78.7 ± 66.7 months in the LE + RT group and 70.5 ± 45.7 months in the LE group. Cancer eventually recurred in six patients (9.1 %; two in the LE + RT group and four in the LE group). In five of these patients, recurrence occurred within 4 years after the initial treatment. The other patient, who was in the LE group, exhibited multiple lymph node metastases at the 116-month follow-up. Kaplan–Meier estimates of recurrence-free survival at 5 years after treatment were 96.8 % in the LE + RT group and 97 % in the LE group (P = 0.657).
RT after LE of early rectal cancer with deep submucosal invasion might not improve recurrence-free survival compared with LE alone.
KeywordsLocal excision Rectal cancer Deep submucosal invasion
Seohyun Lee, Chang Gok Woo, Hyo Jeong Lee, Kyung-Jo Kim, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Young Soo Park, Jin-hong Park, Jong Hoon Kim, Seok-Byung Lim, Jin Cheon Kim, Chang Sik Yu, and Dong-Hoon Yang have no conflicts of interest or financial ties to disclose.
- 1.NCCN (2014) NCCN clinical practice guidelines in oncology. Rectal cancer, Version 3. http://www.nccn.org/professionals/physician_gls/pdf/rectal.pdf. Accessed Mar 14 2014
- 9.Lee SH, Shin SJ, Park DI, Kim SE, Jeon HJ, Kim SH, Hong SP, Hong SN, Yang DH, Lee BI, Kim YH, Kim HS, Kim HJ, Yang SK, Kim HJ, Multi-Society Task Force for Development of Guidelines for Colorectal Polyp Screening S, Management (2012) Korean guideline for colonoscopic polypectomy. Clin Endosc 45:11–24PubMedCentralCrossRefPubMedGoogle Scholar
- 11.Peeters KC, van de Velde CJ, Leer JW, Martijn H, Junggeburt JM, Kranenbarg EK, Steup WH, Wiggers T, Rutten HJ, Marijnen CA (2005) Late side effects of short-course preoperative radiotherapy combined with total mesorectal excision for rectal cancer: increased bowel dysfunction in irradiated patients–a Dutch colorectal cancer group study. J Clin Oncol 23:6199–6206CrossRefPubMedGoogle Scholar
- 18.Olsheski M, Schwartz D, Rineer J, Wortham A, Sura S, Sugiyama G, Rotman M, Schreiber D (2013) A population-based comparison of overall and disease-specific survival following local excision or abdominoperineal resection for stage I rectal adenocarcinoma. J Gastrointest Cancer 44:305–312CrossRefPubMedGoogle Scholar
- 23.Tanaka S, Haruma K, Teixeira CR, Tatsuta S, Ohtsu N, Hiraga Y, Yoshihara M, Sumii K, Kajiyama G, Shimamoto F (1995) Endoscopic treatment of submucosal invasive colorectal carcinoma with special reference to risk factors for lymph node metastasis. J Gastroenterol 30:710–717CrossRefPubMedGoogle Scholar
- 24.Kobayashi H, Mochizuki H, Morita T, Kotake K, Teramoto T, Kameoka S, Saito Y, Takahashi K, Hase K, Oya M, Maeda K, Hirai T, Kameyama M, Shirouzu K, Sugihara K (2011) Characteristics of recurrence after curative resection for T1 colorectal cancer: Japanese multicenter study. J Gastroenterol 46:203–211CrossRefPubMedGoogle Scholar